Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Drug Recalls For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Naropin (ropivacaine HCl) Injection,Rx AstraZeneca L.P. NDA 20-533/S-002 11/2/00 Naropin Indication:for the production of local or regional anesthesia for surgery and for acute pain management. Naropin (ropivacaine HCl) Injection, AstraZeneca, Labeling Revision | Naropin (ropivacaine HCl) Injection, Abraxis BioScience, Labeling Revision | Ropivacaine Hydrochloride Injection, Navinta LLC, Tentative Approval | Ropivacaine Hydrochloride Injection, Navinta, LLC, Tentative Approval | Naropin (ropivacaine hydrochloride monohydrate) Injection, APP Pharmaceuticals, Labeling Revision ^ FDA's latest approval appears at the bottom of this list. ^                                                                                      A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News © 2010 Betterchem.com